Dexpramipexole

DB15130InvestigationalSmall molecule

Dexpramipexole is under investigation in clinical trial NCT01511029 (Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of...

Formula / weight: C₁₀H₁₇N₃S · 211.33 g/mol (avg)
Code names: KNS-760704

Resolves to

Compound

UNIIWI638GUS96CAS104632-28-2ChEMBLCHEMBL249420

Clinical / RWD

PharmGKBPA164742949

Structure

InChIKeyFASDKYOPVNHBLU-SSDOTTSWSA-NSMILESCCCN[C@@H]1CCC2=C(C1)SC(N)=N2

Targets

P35225IL13P05112IL4

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

48Drug interactionsStructured to mechanism, not free text

14Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dexpramipexole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account